Bordios, Jay-an .
HRN: 26-75-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/22/2025
CEFUROXIME 1.5GM (VIAL)
04/22/2025
04/23/2025
IV
1.5gms
Q8hrs X 3 Doses
S/P Repeat CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes